Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Clinical trial NCT04321954 · COMPLETED

Trial details

NCT number: NCT04321954
Sponsor: Massachusetts Eye and Ear Infirmary
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer Advanced Cancer

Start date: 2021-03-09
Primary completion: 2025-05-27
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.